Brokerages Set The Pennant Group, Inc. (NASDAQ:PNTG) Target Price at $34.80

The Pennant Group, Inc. (NASDAQ:PNTG) has received an average recommendation of “Buy” from the eight ratings firms that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating on the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $34.80.

Several research firms have recently commented on PNTG. Truist Financial raised The Pennant Group from a “hold” rating to a “buy” rating and increased their price objective for the company from $28.00 to $34.00 in a report on Tuesday, December 2nd. Stephens reaffirmed an “overweight” rating and set a $40.00 price target on shares of The Pennant Group in a research report on Thursday, October 9th. Weiss Ratings reissued a “hold (c)” rating on shares of The Pennant Group in a research report on Monday. Wells Fargo & Company upgraded shares of The Pennant Group from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $29.00 to $31.00 in a research note on Tuesday, November 18th. Finally, Royal Bank Of Canada raised their target price on shares of The Pennant Group from $34.00 to $39.00 and gave the company an “outperform” rating in a research note on Monday, November 17th.

The Pennant Group Price Performance

Shares of NASDAQ PNTG opened at $29.73 on Friday. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.04 and a quick ratio of 1.04. The business has a 50-day moving average of $26.24 and a 200-day moving average of $25.78. The stock has a market capitalization of $1.03 billion, a price-to-earnings ratio of 39.64, a PEG ratio of 2.39 and a beta of 1.31. The Pennant Group has a fifty-two week low of $21.18 and a fifty-two week high of $30.46.

The Pennant Group (NASDAQ:PNTG) last released its earnings results on Wednesday, November 5th. The company reported $0.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.01. The Pennant Group had a return on equity of 9.37% and a net margin of 3.15%.The business had revenue of $229.04 million for the quarter, compared to analyst estimates of $221.96 million. The Pennant Group has set its FY 2025 guidance at 1.140-1.180 EPS. As a group, sell-side analysts predict that The Pennant Group will post 0.75 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in PNTG. Invesco Ltd. increased its holdings in shares of The Pennant Group by 9.9% in the first quarter. Invesco Ltd. now owns 48,945 shares of the company’s stock valued at $1,231,000 after purchasing an additional 4,425 shares during the last quarter. Nuveen LLC bought a new stake in shares of The Pennant Group during the 1st quarter worth about $9,181,000. American Century Companies Inc. bought a new stake in shares of The Pennant Group during the 1st quarter worth about $519,000. Algert Global LLC grew its stake in The Pennant Group by 39.9% in the 1st quarter. Algert Global LLC now owns 136,441 shares of the company’s stock valued at $3,431,000 after buying an additional 38,890 shares during the last quarter. Finally, Versor Investments LP raised its holdings in The Pennant Group by 6.2% in the 1st quarter. Versor Investments LP now owns 12,000 shares of the company’s stock valued at $302,000 after acquiring an additional 700 shares during the period. 85.88% of the stock is currently owned by institutional investors.

The Pennant Group Company Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.